Clinical Trials Directory

Trials / Completed

CompletedNCT00719576

Superiority of MACI® Versus Microfracture Treatment in Patients With Symptomatic Articular Cartilage Defects in the Knee

A Prospective, Randomized, Open-label, Parallel-group, Multi-center Study to Demonstrate the Superiority of MACI® Versus Arthroscopic Microfracture for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle Including the Trochlea.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Vericel Corporation · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The objective of this trial is to demonstrate superior efficacy and safety of MACI compared with arthroscopic microfracture in the treatment of patients (aged 18 to 55 years) with symptomatic articular cartilage defects of the knee.

Detailed description

This is a prospective, randomized, open-label, parallel-group, multicenter study designed to investigate the outcome of MACI implant versus arthroscopic microfracture in the treatment of articular cartilage defects in the knee in patients between ages of 18 and 55 years. All patients who meet the eligibility criteria and are considered suitable for inclusion will have a cartilage biopsy taken prior to randomization to study treatment. Eligible patients will then be randomized during the index arthroscopy procedure to receive either MACI implant or microfracture treatment. Patients randomized to treatment with MACI implant will return within approximately 4 to 8 weeks of the index arthroscopy to undergo the chondrocyte implantation procedure via arthrotomy. Patients randomized to microfracture will undergo the procedure during the index arthroscopy. Patients will be assessed post-arthroscopy and post-arthrotomy at intervals during 2 years follow-up. Evaluations include adverse events, functional and pain outcomes, arthroscopic and histologic evaluation and magnetic resonance imaging (MRI).

Conditions

Interventions

TypeNameDescription
BIOLOGICALautologous cultured chondrocytes on porcine collagen membraneImplantation via mini-arthrotomy
PROCEDUREMicrofractureMicrofracture performed by arthroscopic surgery

Timeline

Start date
2008-07-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2008-07-21
Last updated
2021-05-12
Results posted
2017-12-14

Locations

20 sites across 7 countries: Czechia, France, Netherlands, Norway, Poland, Sweden, United Kingdom

Source: ClinicalTrials.gov record NCT00719576. Inclusion in this directory is not an endorsement.